“EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA: Empiric glycopeptide use in neutropenic fever” (2022) Mediterranean Journal of Hematology and Infectious Diseases, 14(1), p. e2022039. doi:10.4084/MJHID.2022.039.